Press Release Summary:
The Kaluza C Flow Cytometry Analysis Software allows user to process multi-color files with up to 20 million events and set plot resolution based on the gate level. The tool is embedded with Boolean gate formation and auto-gating for improving the analysis of complex data sets. It provides user management tools ranging from report page generation to auditing work levels and traceability. The Kaluza C enables operator to focus on limited number of events for preserving the integrity of the scatter plot.
Original Press Release:
Beckman Coulter Launches Kaluza C Flow Cytometry Data Analysis System for Clinical Labs
Software Enhances Workflow for Mid to High Complexity Testing
MIAMI, USA − (September 28, 2018) − Beckman Coulter has launched the Kaluza C Flow Cytometry Analysis Software, an advanced data analysis system for the clinical laboratory. The new software streamlines clinical QC reporting and addresses standardization issues in flow cytometry. Kaluza C is both CE- marked and listed with the FDA. It builds on the company’s existing Kaluza Analysis software, which is already an essential analysis tool for life science researchers.
Kaluza C software improves the visualization and analysis of rare events. It makes it possible to process large, multi-color, files with up to 20 million events and set the plot resolution according to the gate level. Further, it enables the operator to focus on a limited number of events to preserve the integrity of the scatter plot. Tools such as easy Boolean gate formation and autogating are also incorporated to improve the analysis of complex data sets. It takes less than a second to adjust the compensation and calculate compensation values.
Dr. Mario Koksch, Vice President and General Manager of Beckman Coulter’s Cytometry Business Unit, explained: “Kaluza C offers laboratories the opportunity to improve their clinical reporting. It provides support at several levels, from quality control and regulatory compliance to ease of use and advanced user management tools.
“Complex, clinical reporting can now be done in minutes, helping to improve workflow, reduce turnaround time (TAT) and enhance the diagnostic pathway.”
Kaluza C incorporates quality control visualization tools for regulatory and quality control compliance. The software also offers a range of user management tools, from report page generation to auditing work levels and traceability, and enables easy exporting of data into the main laboratory information system. It can analyze clinical data from any cytometer that complies with the official Flow Cytometry Standard (FCS).
Dr Koksch added: “Meeting regulatory requirements for complex flow cytometry testing is demanding on both time and expertise. Kaluza C empowers clinical flow cytometrists, giving them the confidence to approach their work in a different way and so achieve greater efficiencies.”
About Beckman Coulter Life Sciences
Beckman Coulter Life Sciences develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. For more than 80 years, our products have been making a difference in peoples' lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. More information: www.beckman.com. Follow Beckman Coulter Life Sciences on Twitter @BCILifeSciences; LinkedIn and https://www.facebook.com/BCILifeSciences.
Jennie Wilde, PR Consultant
P | +44 (0)20 38148445